Publication Date:
2013-05-03
Description:
CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer Oncogene 32, 2282 (02 May 2013). doi:10.1038/onc.2012.251 Authors: C Xie, X H Jiang, J T Zhang, T T Sun, J D Dong, A J Sanders, R Y Diao, Y Wang, K L Fok, L L Tsang, M K Yu, X H Zhang, Y W Chung, L Ye, M Y Zhao, J H Guo, Z J Xiao, H Y Lan, C F Ng, K M Lau, Z M Cai, W G Jiang & H C Chan
Keywords:
CFTRmiR-193buPA
Print ISSN:
0950-9232
Topics:
Medicine
Permalink